Dronedarone (SR33589)
Sponsors
Sanofi
Conditions
Atrial FibrillationAtrial FlutterCongestive Heart Failure
Phase 2
Phase 3
A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation
CompletedNCT00174785
Start: 2005-06-30End: 2008-03-31Updated: 2010-01-12
American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm
CompletedNCT00259376
Start: 2001-11-30End: 2003-09-30Updated: 2010-02-15
EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)
CompletedNCT00259428
Start: 2001-11-30End: 2003-08-31Updated: 2010-02-09
Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
CompletedNCT00489736
Start: 2007-06-30End: 2008-10-31Updated: 2010-02-18
European Trial of Dronedarone in Moderate to Severe Congestive Heart Failure
TerminatedNCT00696631
Start: 2002-06-30End: 2003-08-31Updated: 2010-02-15
European Study of Dronedarone in Atrial Fibrillation
CompletedNCT00697086
Start: 2002-08-31End: 2004-06-30Updated: 2009-07-30